(CNN)Despite President Donald Trump’s enthusiasm for the drug hydroxychloroquine to treat coronavirus, the federal funding powerhouse led by Dr. Anthony Fauci isn’t spending any money on it, and clinical trials for it are lagging behind other drug studies, according to a CNN investigation. At a White House briefing last week, Trump said hydroxychloroquine, which is used to treat malaria, lupus, and rheumatoid arthritis, shows “tremendous promise” of working against coronavirus as well. “I think it’s going to be great,” he said. “We’re quickly studying this drug.” But the National Institute of Allergy and Infectious Diseases isn’t sponsoring any studies on hydroxychloroquine, according to a statement from the agency, which added that the agency is “considering” trials that examine the drug or its analogue chloroquine as a potential treatment for Covid-19. studies. On its website, NIAID mentions several drug therapies it’s supporting to fight coronavirus, but not hydroxychloroquine. The Biomedical Advanced Research and Development Authority, another federal agency, also lists its coronavirus measures on its website, but hydroxychloroquine is not among them. Hydroxychloroquine clinical trials Last month, a Chinese study theorized that hydroxychloroquine might work against coronavirus by preventing it from binding to human cells. Trump was so positive about the


Continue To Full Article